Connection

Arnav Agarwal to Cost-Benefit Analysis

Back to Details
This is a "connection" page, showing publications Arnav Agarwal has written about Cost-Benefit Analysis.
Arnav Agarwal
Connection Strength
0.198
Cost-Benefit Analysis
  1. Does evidence support the use of cat allergen immunotherapy? Curr Opin Allergy Clin Immunol. 2018 08; 18(4):350-355.
    View in: PubMed
    Score: 0.090
  2. Funding characteristics of randomised clinical trials supported by the Swiss National Science Foundation: a retrospective cohort study. Swiss Med Wkly. 2018; 148:w14587.
    View in: PubMed
    Score: 0.087
  3. Systematic review on costs and resource use of randomized clinical trials shows a lack of transparent and comprehensive data. J Clin Epidemiol. 2018 04; 96:1-11.
    View in: PubMed
    Score: 0.022
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.